(0.25%) 5 144.25 points
(0.14%) 38 495 points
(0.40%) 17 917 points
(-0.72%) $83.25
(1.61%) $1.954
(-0.21%) $2 342.30
(-0.07%) $27.52
(2.67%) $946.70
(-0.03%) $0.934
(-0.06%) $11.02
(-0.27%) $0.798
(1.35%) $93.11
0.81% KRW 6 200.00
Live Chart Being Loaded With Signals
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments...
Stats | |
---|---|
Dagens volum | 97 884.00 |
Gjennomsnittsvolum | 689 294 |
Markedsverdi | 408.25B |
EPS | KRW0 ( 2024-04-22 ) |
Neste inntjeningsdato | ( KRW0 ) 2024-05-13 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW7.24 (0.12%) |
Volum Korrelasjon
Bukwang Pharmaceutical Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Bukwang Pharmaceutical Korrelasjon - Valuta/Råvare
Bukwang Pharmaceutical Økonomi
Annual | 2023 |
Omsetning: | KRW125.93B |
Bruttogevinst: | KRW50.05B (39.74 %) |
EPS: | KRW-457.67 |
FY | 2023 |
Omsetning: | KRW125.93B |
Bruttogevinst: | KRW50.05B (39.74 %) |
EPS: | KRW-457.67 |
FY | 2022 |
Omsetning: | KRW190.91B |
Bruttogevinst: | KRW79.43B (41.61 %) |
EPS: | KRW-62.07 |
FY | 2021 |
Omsetning: | KRW182.49B |
Bruttogevinst: | KRW75.76B (41.51 %) |
EPS: | KRW-8.74 |
Financial Reports:
No articles found.
Bukwang Pharmaceutical
Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.